Victorino G P, Wisner D H, Tucker V L
Departments of Surgery and Human Physiology, School of Medicine, University of California, Davis, Davis, California, USA.
J Trauma. 2001 Mar;50(3):535-9. doi: 10.1097/00005373-200103000-00020.
Both endothelin-1 (ET-1) and nitric oxide (NO) are released by the endothelium and are implicated in modulating the permeability of the endothelial barrier. The present study was designed to examine the interaction between ET-1 and NO and its influence on microvascular permeability as well as the role of NO in maintaining microvascular permeability. To isolate the direct effect of ET-1 and NO, experiments were conducted under conditions where hydraulic and oncotic pressures were controlled.
Postcapillary venules in the rat mesentery were perfused in situ and paired measurements of hydraulic permeability (Lp) obtained using the modified Landis micro-occlusion method. The effect of basal endogenous NO was tested by measuring the effects of perfusion with the NO synthase inhibitor Nw-nitro-L-arginine-methyl-ester (L-NAME) (100 micromol/L) on Lp (n = 6). In addition, Lp measured after a 15-minute perfusion with L-NAME (100 micromol/L) was compared with measures of Lp obtained after perfusion with a combined mixture of L-NAME (100 micromol/L) and ET-1 (80 pmol/L) (n = 6).
Units for Lp are mean +/- SE x 10(-8) cm x sec(-1) x cm H2O(-1). Under basal conditions, in the absence of exogenous ET-1, NO synthase inhibition led to a significant increase in Lp from 5.7 +/- 0.5 to 9.8 +/- 1.4 (p = 0.02). Compared with L-NAME alone, ET-1 + L-NAME significantly decreased Lp from 10.3 +/- 0.8 to 5.7 +/- 0.6 (p = 0.006).
Constitutive release of NO from the microvascular endothelium plays a role in maintaining a basal level of microvascular permeability. Decreases in microvascular permeability seen with the administration of ET-1 are not mediated via the release of NO. These findings suggest important roles for ET-1 and NO in maintaining and modulating microvascular permeability.
内皮素 -1(ET -1)和一氧化氮(NO)均由内皮细胞释放,且与调节内皮屏障的通透性有关。本研究旨在探讨ET -1与NO之间的相互作用及其对微血管通透性的影响,以及NO在维持微血管通透性中的作用。为了分离ET -1和NO的直接作用,实验在控制液压和胶体渗透压的条件下进行。
对大鼠肠系膜中的毛细血管后微静脉进行原位灌注,并使用改良的兰迪斯微闭塞法成对测量液压通透性(Lp)。通过测量用一氧化氮合酶抑制剂Nω-硝基 -L -精氨酸甲酯(L -NAME)(100 μmol/L)灌注对Lp的影响来测试基础内源性NO的作用(n = 6)。此外,将用L -NAME(100 μmol/L)灌注15分钟后测得的Lp与用L -NAME(100 μmol/L)和ET -1(80 pmol/L)的混合混合物灌注后获得的Lp测量值进行比较(n = 6)。
Lp的单位为平均值±标准误×10⁻⁸ cm×秒⁻¹×cm H₂O⁻¹。在基础条件下,在没有外源性ET -1的情况下,一氧化氮合酶抑制导致Lp从5.7±0.5显著增加到9.8±1.4(p = 0.02)。与单独使用L -NAME相比,ET -1 + L -NAME使Lp从10.3±0.8显著降低到5.7±0.6(p = 0.006)。
微血管内皮细胞中NO的组成性释放对维持微血管通透性的基础水平起作用。给予ET -1后微血管通透性的降低不是通过NO的释放介导的。这些发现表明ET -1和NO在维持和调节微血管通透性中起重要作用。